Article

The Japan Times on 2021-03-15 18:00

India’s smart vaccine diplomacy

India is a global pharmaceutical powerhouse, manufacturing some 20% of all generic medicines and accounting for as much as 62% of global vaccine ...

Related news

SWill India’s Covishield export halt amid coronavirus surge hurt its vaccine diplomacy?scmp.com
Oxford , Asia , India
AIndia’s vaccine diplomacy reaches Taiwan asianjournal.ca
Australia , Taipei City , New Zealand , Singapore , New Delhi
Free vaccines and India’s humanitarian diplomacy The Japan Times
Controversial homegrown vaccine risks derailing India’s rollout thenewstribune.com
Brazil , Mumbai , Bhopal , Râches , Serum Institute
Vaccine diplomacy: Will free shipments pay off for India?csmonitor.com
To counter China, India pursues vaccine diplomacy in South Asia newsday.co.zw
Sri Lanka , Dhaka , Nepal , Bangladesh , Bhutan
India’s approval of homegrown vaccine criticised over lack of data tribuneonlineng.com
Ibadan , Lagos , China , Brazil , Ahmadabad
India’s quick nod to homegrown COVID-19 vaccine seeds doubt Seattle Times
Russia , China , Brazil , United Kingdom , Wardha
US, Indo-Pacific allies to expand India’s vaccine production Seattle Times
India’s Covid-19 Crisis Raises Pressure to Waive Vaccine Patents wsj.com
Colombia , Turkey , Brazil , South Africa , Washington
India’s Serum Institute resumes vaccine exports to COVAX Seattle Times
Canton of Geneva , Africa , Philippines , Indonesia , Tajikistan
Coronavirus | India’s emergency use guidelines allow ‘immediate’ approval of vaccine The Hindu
Russia , The Hindu , United States , United Kingdom , India
Vaccine hesitancy puts India’s gains against virus at risk Star Telegram
Lal , Sikanderpur , Maharashtra , Gadchiroli , Kol
WHO gives green light to India’s Covaxin COVID-19 vaccine Sydney Morning Herald
United States , Sydney , Glasgow , Rome , Australia